wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33837017-27878F1D-5C90-41C2-8D4C-51A285AEA67E
Q33837017-27878F1D-5C90-41C2-8D4C-51A285AEA67E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33837017-27878F1D-5C90-41C2-8D4C-51A285AEA67E
Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
P2860
Q33837017-27878F1D-5C90-41C2-8D4C-51A285AEA67E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33837017-27878F1D-5C90-41C2-8D4C-51A285AEA67E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c92fd65c7c94cb60c9504232abaf806b5d7d3729
P2860
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial